Policy and Medicine Compliance Update August 2023 Issue Features: CMS Open Payments Reporting for 2023, Impact of Life Science Compliance, HHS-OIG revision of compliance guidance, and US Final Regulation for Drug Price Negotiations Read more
FDA: Food and Drug Administration Safety and Innovation Act (FDASIA) and Patient Focused Drug Development Read more